KG-LIME: predicting individualized risk of adverse drug events for multiple sclerosis disease-modifying therapy.
The aim of this project was to create time-aware, individual-level risk score models for adverse drug events related to multiple sclerosis disease-modifying therapy and to provide interpretable explanations for model prediction behavior.
Author(s): Patterson, Jason, Tatonetti, Nicholas
DOI: 10.1093/jamia/ocae155